Andrew Kelley has been appointed chief operating officer of NextPharma Technologies and Pierre Delavaud has been appointed executive vice president sales and marketing. Also, Matthew Wilder has been appointed vice president U.S. sales and marketing.   Mr. Kelley has more than 27 years of experience in the pharmaceutical industry. Most recently, he led manufacturing operations at Patheon. Mr. Delavaud joins the company from SkyePharma, and previously spent 14 years at Catalent, where he held vari...